Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) - An Early Feasibility Study

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

UCon is a medical device for treatment of the symptoms of overactive bladder (OAB) and bowel dysfunction (BD). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder/bowel musculature e.g., suppress undesired bladder/bowel activity to relieve the symptoms of the patient. This clinical investigation is designed as a single-arm, prospective, multi-centre, and early feasibility study.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Participant is female

• Participant is ≥ 18 years of age.

• Participant is diagnosed with OAB or BD.

• OAB: Urinary urgency usually with one or more of the following:

• i. Urinary urgency incontinence (≥1 per/week). ii. Urinary frequency (≥8 voiding/day without polyuria). iii. Nocturia (≥2 voiding/night without nocturnal polyuria).

• BD: One or more of the following:

• i. Faecal urgency (≥3 urgencies pr. week) together with registration of urgency in St. Mark´s and a St. Mark´s score ≥9.

• ii. Faecal incontinence (urge/passive) (≥1 per/week).

• Participant is able to communicate, provide feedback, understand and follow instructions during the course of the investigation, including using the device at home.

Locations
Other Locations
Denmark
Aarhus University Hospital
RECRUITING
Aarhus
Herlev Hospital
RECRUITING
Herlev
Odense University Hospital
RECRUITING
Odense
Contact Information
Primary
Dianna Mærsk Knudsen
dmk@innoconmedical.dk
40517712
Time Frame
Start Date: 2024-01-12
Estimated Completion Date: 2026-01-01
Participants
Target number of participants: 20
Treatments
Experimental: Electrical stimulation
Electrical stimulation to the dorsal genital nerve.
Sponsors
Leads: InnoCon Medical
Collaborators: Odense University Hospital, Herlev Hospital, Aarhus University Hospital

This content was sourced from clinicaltrials.gov